Lorenzo D.
- Country
- Italy
- Department
- Immunologia-Reumatologia-Allergologia e Malattie Rare
Research Overview
- A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBEXELIMAB IN PATIENTS WITH IGG4-RELATED DISEASE (INDIGO)
- A Phase 3 Randomized Controlled Trial to Evaluate the Efficacy and Safety of Rilzabrutinib in Adults with Active IgG4-Related Disease
- Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Adults With Active Psoriatic Arthritis: A Phase 3 Extension Study
Data & Insights
Has run more than one trial at 391 of 670 partner sites.
Specializations
Lupus Research
Specializes in various forms of lupus erythematosus, particularly focusing on cutaneous manifestations and renal complications.
- Cutaneous Lupus (CLE)
- Lupus Nephritis
- Systemic Lupus Erythematosus (SLE)
Investigates innovative therapeutic approaches for both skin-specific and systemic lupus manifestations.
Eosinophilic Conditions
Focuses on rare eosinophilic disorders and their treatment approaches through targeted therapies.
- Hypereosinophilic Syndrome (HES)
- Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Explores novel therapeutic options for managing eosinophil-related inflammatory conditions.
Autoimmune Disorders
Conducts research on various autoimmune conditions affecting multiple organ systems.
- Systemic Sclerosis
- Sjögren's Syndrome
- IgG4-Related Disease
- Polymyalgia Rheumatica
Studies innovative treatments for complex autoimmune manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
